With an established presence in Europe, the Middle East, North Africa, Asia, and Latin America, the FarmaImpresa Group supports international companies and distributors in the development and marketing of medical devices, dietary supplements, and aesthetic medicine products. The experience gained in over 40 countries enables the group to effectively address the diverse regulatory and commercial requirements of global markets.
Our Company
Gruppo Farmaimpresa is a CDMO specializing in the development, registration, and contract manufacturing of dietary supplements, substance-based medical devices, and dermocosmetics. In addition to customized projects, the company offers one of the most comprehensive “Ready to Market” product lines in the industry, consisting of solutions backed by clinical studies, scientific dossiers, and regulatory documentation. Thanks to our integrated expertise in research and development, regulatory affairs, manufacturing, and private label, we support companies in over 40 countries in the development and commercialization of health and wellness products.
+
0
We operate in more than 40 countries
+
0
More than 1000 types of products
+
0
10 therapeutic areas covered
+
0
30 pharmaceutical forms provided
Our Market
International presence in over 40 countries
OUR MISSION
The FarmaImpresa Group supports companies in the healthcare sector through an integrated model that combines research and development, regulatory affairs, clinical trials, contract manufacturing, and Ready-to-Market solutions. We operate as a CDMO partner for the development of substance-based medical devices, dietary supplements, dermocosmetics, and aesthetic medicine products, supporting our clients at every stage of the process, from formulation to commercialization.
“We are our own customers; their satisfaction is our goal”
We believe in the value of long-lasting relationships, quality, and expertise. That is why we support companies and distributors throughout the entire product development process, offering scientific, regulatory, manufacturing, and marketing expertise for medical devices, dietary supplements, dermocosmetics, and solutions for aesthetic medicine.
Frequently Asked Questions About the FarmaImpresa Group
What is Gruppo FarmaImpresa?
Gruppo FarmaImpresa is an Italian CDMO specializing in the development, registration, and contract manufacturing of medical devices based on active ingredients, dietary supplements, dermocosmetics, and solutions for aesthetic medicine.
What services does Gruppo FarmaImpresa offer?
The FarmaImpresa Group offers formulation development, contract manufacturing, private label services, regulatory affairs, clinical trials, and marketing support to companies in the healthcare sector.
In which countries does the FarmaImpresa Group operate?
The FarmaImpresa Group works with companies and distributors in over 40 countries across Europe, the Middle East, North Africa, Asia, and Latin America.
What does "Ready To Market" mean?
Ready-to-Market solutions are pre-developed formulations backed by technical, scientific, and regulatory documentation, enabling partners to reduce the time required to bring new products to market.
What is the difference between PJPharma and Armonita?
PJPharma is the Ready-to-Market line dedicated to medical devices, dietary supplements, and health solutions. Armonita is the group’s brand focused on aesthetic medicine and premium cosmetics.
Does the FarmaImpresa Group also provide support for regulatory matters?
Yes. The company provides regulatory expertise to support the registration, regulatory compliance, and technical documentation of products intended for international markets.
Does the FarmaImpresa Group conduct clinical trials?
The FarmaImpresa Group supports the development of scientific evidence through clinical trials and research aimed at validating medical devices, dietary supplements, and other health solutions.
Who does Gruppo FarmaImpresa serve?
The FarmaImpresa Group collaborates with pharmaceutical, nutraceutical, and cosmetics companies, as well as distributors and other players in the healthcare sector, who are interested in developing or marketing products in domestic and international markets.